wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37731321-38AD3EF7-9583-4696-B9E2-E0CCE348085F
Q37731321-38AD3EF7-9583-4696-B9E2-E0CCE348085F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37731321-38AD3EF7-9583-4696-B9E2-E0CCE348085F
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
P2860
Q37731321-38AD3EF7-9583-4696-B9E2-E0CCE348085F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37731321-38AD3EF7-9583-4696-B9E2-E0CCE348085F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
42e52958c8a51910133f664a23503e5e99b1ef11
P2860
Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.